Scholar Rock’s stock price increased by 362% after the company announced data from the Phase III SAPPHIRE trial of ...

Johnson & Johnson has discontinued its SunRISe-2 study for TAR-200 in bladder cancer patients not undergoing radical ...

The US FDA has imposed a clinical hold on Kezar Life Sciences’ IND application for zetomipzomib, aimed at treating lupus ...

Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess casdatifan plus volrustomig for renal ...

The company has received clearance from the US FDA to start an open-label Phase I trial for RespiRx nicotine inhaler in ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Immutep has concluded subject enrolment in the Phase II segment of the AIPAC-003 trial of eftilagimod alpha (efti) to treat ...

The BHF claims women are less likely than men to seek medical attention when experiencing a cardiac episode.

On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy ...

It is common for sponsors to switch digital platforms between clinical trial phases, but sponsors can achieve much by using ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.

Johnson & Johnson has reported Phase III data where CARVYKTI improved overall survival in patients with multiple myeloma.